From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Age (years) | General population | Source | |
---|---|---|---|
Mean | SE | ||
0-12 | 0.92 | 0.11 | -- |
13-15 | 0.90 | 0.15 | 21 |
16-37 | 0.85 | 0.18 | 21 |
38-54 | 0.83 | 0.01 | 22 |
55-64 | 0.77 | 0.02 | 22 |
65-74 | 0.80 | 0.01 | 22 |
75-89 | 0.75 | 0.01 | 22 |